Control Bionics

We’re pleased to welcome Stephen Rix as Chairman of Control Bionics (ASX: $CBL). A long-standing shareholder since 2016, Stephen brings 20+ years of governance and tech leadership as we scale our #neurotech globally. #ASX #CBL #MedTech

Control Bionics integrates with Apple's BCI protocol @control_bionics proactiveinvestors.com/companies/news… #ControlBionics #AppleIntegration #Apple #AssistiveTech #AccessibleTechnology #MedicalDevices

Biocurious: Control Bionics says outwitting the world’s richest man is a no-brainer stockhead.com.au/uncategorized/…

A record year and we’re just getting started! ✅ Revenue up 15% YoY ✅ HCPCS driving US growth ✅ NeuroNode® Only scaling globally ✅ NeuroStrip® strong trial results ✅ NeuroBounce® now in AU 📄 Q4 Update: bit.ly/46AihwU #ASX $CBL #ControlBionics #Medtech #Neurotech

CEO Jeremy Steele on AusbizTV breaks down how $CBL is on track for record FY25 revenue — and what’s powering the momentum. 🧠 Sports & rehab market traction 📈 NeuroStrip® commercialisation 🔓 FY26 catalysts 🎥 Watch: vimeo.com/1094634308 #ASX #MedTech #NeuroTech #EMG

Control Bionics (#ASX: $CBL) CEO Jeremy Steele live on @ausbiztv today! We're on track for record FY25 revenue, backed by strong U.S. growth and traction in sports performance, #rehab & assistive tech. 🔗 Watch live: ausbiz.com.au @ 3:10pm AEDT #Neurotech #sportstech

Control Bionics bounces toward record revenue in FY25 buff.ly/4T0TQaE #ASX #Health $CBL @Control_Bionics

📈 $CBL trading update: FY25 shaping up as a record revenue year. Core business accelerating + NeuroStrip® scaling into new markets. Read more: bit.ly/4jN5Al6 #ASX #CBL #EMG #MedTech #RehabTech #SportsPerformance

Thanks to @StockheadAU for this article on the Big Freeze shining a spotlight on #MND. At Control Bionics, we’re helping people living with MND/ALS regain communication and control through our NeuroNode® technology. #ASX #Medtech $CBL #AssistiveTech #NeuroNode

📢 Control Bionics at #ImpactInvestingSummit Our CEO Jeremy Steele spoke on the panel "Scaling Solutions Helping Young Australians with Disabilities", sharing how #tech #innovation is improving access to assistive communication, mobility & rehab. #AssistiveTechnology #NeuroTech

📢 Control Bionics at #ATIA2025! Industry leaders embraced our new HCPCS code approval, expanding access to #NeuroNode®. This milestone opens new distribution opportunities, advancing #Accessibility with innovative #AssistiveTechnology.

Thanks to @StockheadAU TV for this superb roundup of our key 2024 achievements and what we're aiming for in 2025! ASX: $CBL on #Vimeo vimeo.com/1041006682

Strong growth boosts Control Bionics’ US revenue in H1 FY25 buff.ly/3VHCJFS #ASX #ASX200 $CBL @Control_Bionics

📢 1H FY25 Update – Strong U.S. Growth Control Bionics (#ASX: $CBL): ✅ US revenue +15% YoY (1H FY25), +30% expected for H2 CY24 ✅ First #DROVE distribution partnership in AU ✅ DROVE #FDA approval in #USA - finalising clinical trial partner ✅ A$700k annualised cost savings

Join us today for our Investor briefing. Register here: bit.ly/3Bts4rt

Control Bionics leaps into new US and Japanese markets with strategic deals buff.ly/49LHS5C #ASX #ASX200 $CBL @Control_Bionics

Big milestone for Control Bionics (#ASX: $CBL): First commercial agreements for NeuroStrip® technology in US sports & Japanese #rehabilitation , driving SaaS revenue, hardware sales, & global growth. #NeuroStrip #ControlBionics #SportsPerformance Read: bit.ly/3ZVAJwi

Thanks to @australian for featuring Control Bionics (ASX:CBL) and highlighting: ✅ U.S. expansion with NeuroNode & Medicare reimbursement secured ✅ New product launch: NeuroStrip ✅ Strategic shift to wholesale distribution Read: bit.ly/3US6Article #AssistiveTech

Control Bionics boosts revenue with faster NDIS approvals and new leasing program buff.ly/47T9rZA #ASX #ASX200 $CBL @Control_Bionics